64
Participants
Start Date
August 21, 2007
Primary Completion Date
July 28, 2008
Study Completion Date
January 28, 2009
hydrocortisone (modified release), oral tablet 20 and 5 mg
The modified release hydrocortisone tablet was administered orally o.d. at 8 AM in the fasting state. The dose was the same as patients have had before entering the trial
Hydrocortisone, oral tablet, 10 mg
The reference drug was administered orally thrice daily (at 8 AM, 12 AM and 4 PM). The morning dose was administered in the fasting state. The total daily dose was the same as in the experimental treatment arm.
Lead Sponsor
Shire
INDUSTRY